a public good project by the
Synthesis
Company
of California

© 2026

Morie A. Gertz | doi.page

0 works0 citations0 h-index

Morie A. Gertz

Toyota Motor Corporation (Switzerland)(CH)Mayo Clinic(US)WinnMed(US)Mayo Clinic in Arizona(US)Mayo Clinic in Florida(US)

Publications by Year

Research Areas

Multiple Myeloma Research and Treatments, Amyloidosis: Diagnosis, Treatment, Outcomes, Chronic Lymphocytic Leukemia Research, Protein Degradation and Inhibitors, Parathyroid Disorders and Treatments

Most-Cited Works

→ International uniform response criteria for multiple myeloma(2006)2,623 cited
→ Review of 1027 Patients With Newly Diagnosed Multiple Myeloma(2003)2,410 cited
→ Improved survival in multiple myeloma and the impact of novel therapies(2007)2,238 cited
→ CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION(1998)1,525 cited
→ Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis(2005)1,406 cited
→ Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis(2018)1,389 cited

→ Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients(2013)

1,380 cited

→ Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements(2012)1,099 cited

→ Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis(2004)958 cited

→ New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes(2012)948 cited